Latest News
  • eTheRNA immunotherapies and Ghent University Announce mRNA Delivery Collaboration and License Agreement
  • Generate Life Sciences Establishes Newborn Stem Cell Manufacturing Facility to Support the Development of Personalized Therapeutics
  • Cellares and Poseida Therapeutics Partner to Accelerate Cell Therapy Manufacturing
  • eTheRNA immunotherapies and Ghent University Announce mRNA Delivery Collaboration and License Agreement
cancer treatment images
eTheRNA immunotherapies and Ghent University Announce mRNA Delivery Collaboration and License Agreement

eTheRNA immunotherapies and Ghent University Announce mRNA Delivery Collaboration and License Agreement Belgium-based eTheRNA immunotherapies has established a collaboration and licence agreement with Ghent University for mRNA delivery with enhanced thermostability, biodegradability and safety. eTheRNA will receive worldwide commercialisation rights for the new generation of lipid nanoparticle (LNP) formulations co-developed with the university’s research group […]

The Japanese pharmaceutical company JCR will set up its European logistics platform for the distribution of its products in Luxembourg

Excerpt: JCR Pharmaceuticals is a Japanese pharmaceutical company specialising in the research, manufacture and sale of pharmaceutical products for the treatment of rare and genetic diseases. As part of his working visit to Japan, the Minister of the Economy, Franz Fayot, concluded an agreement with JCR Pharmaceuticals pour établir la plate-forme logistiqu on 2 December […]

South Africa expansion delivers growth opportunities for Biocair

Excerpt: Biocair has invested heavily in the expansion of its South Africa operation with the opening of two new offices.   Article: The pharmaceutical, biotech and life science logistics specialist is growing its presence in Cape Town and Durban as part of the company’s efforts to continuously improve its services in the cities.   Biocair […]

Mitsubishi Logistics builds blockchain tracker for drug deliveries

Article Summary: Mitsubishi Logistics has harnessed the power of blockchain to allow clients to track outsourced pharmaceutical shipments, as a way to guarantee the products are kept under proper conditions the whole way. The company in 2015 launched a refrigerated delivery service that meets stricter standards for the transportation of drugs, called Good Distribution Practice […]

Etihad Cargo obtains CEIV Pharma recertification

Article: Etihad Cargo has been awarded the Center of Excellence for Independent Validators (CEIV) Pharma recertification by the International Air Transport Association (IATA). Etihad Cargo achieved IATA CEIV Pharma recertification following an audit by independent validators that assessed the carrier’s capacity to control and enhance its processes. The audit focused on the carrier’s quality management […]

Bridging Supply Chain Gaps in Clinical Trial Logistics for mRNA Vaccines

Article Summary: The rapid spread of the original virus strain and its subsequent variants across the globe highlighted the importance of vaccine technologies which were capable of swift deployment for human trials with efficacy and safety remaining top priorities.   Challenges in the mRNA vaccine supply chain As mRNA vaccines take centre stage, the challenges […]

Major AUD$280 million investment to deliver mRNA 2.0

Excerpt Sanofi, one of the world’s largest vaccine innovators, has partnered with the Queensland Government to inject AUD$280 million into next generation mRNA vaccine research in Queensland. Article Summary Sanofi and Queensland Premier Annastacia Palaszczuk today announced the creation of the Translational Science Hub, which will connect top researchers in Queensland with those at the […]

Phase 2 trial of ChulaCov19 BNA159 mRNA Vaccine to start in Australia

Excerpt ChulaCov19 mRNA vaccine was found safe and immunogenic for primary immunization in clinical trials in Thailand. The Australian trial will evaluate the safety and immunogenicity of a booster dose of ChulaCov19 BNA159 mRNA vaccine in healthy volunteers. The collaborators of the trial are Chulalongkorn University, BioNet and Technovalia. Article Summary The phase 2 trial […]

Vaxxas raises US$23 million (A$34 million) to develop needle-free vaccines, including a COVID-19 vaccine candidate of the next generation

Excerpt Vaxxas will advance numerous vaccination programmes in the clinic and build up manufacturing resources for commercial production. More than US$67 million (A$100 million) in non-dilutive financial support has been provided and pledged via contracts with US and Australian government agencies, industry partners, and international health organisations. Equity investment is being used to leverage this […]

First foreign COVID vaccines head to China from Germany

Excerpt   The vaccines are on the way from China Berlin encourages increased usage, German citizens are encouraged to get vaccinated Batches of vaccines to release after Scholz visit to China There is increased spike in infections hence this batch was introduced   Article Summary Berlin sent its first batch of BioNTech (22UAy.DE) COVID-19 vaccines […]

Polyplus Completes Acquisition of Xpress Biologics

Polyplus, a solution provider for manufacturing of Advanced Therapeutic Medicinal Products from research to commercial grade, has announced the completed acquisition of Xpress Biologics, a Belgian contract development and manufacturing organization (CDMO) specialized in the production of plasmid DNA and protein using microbial expression systems.  Article Summary The acquisition will strategically expand the Polyplus plasmid […]

Neogene Therapeutics to Be Acquired by AstraZeneca

Neogene Therapeutics, Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development, and manufacturing of next-generation T-cell receptor therapies (TCR-Ts), has announced it has entered into a definitive agreement to be acquired by AstraZeneca. Article Summary With a shared goal of bringing cell therapies to patients with solid tumors, Neogene’s expertise in TCR-T discovery, […]

Emmes Launches Cell and Gene Therapy Center to Support Its Client’s Clinical Trials

Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, has announced the creation of a dedicated center to enhance Emmes’ legacy and depth in cell and gene therapy research. Article Summary The new center will emphasis on supporting the clinical trials of its clients who are […]

Explore IMAPAC


    We will send you occasional emails about our Events, Digital Marketing and Market Intelligence services, Upcoming Promotions and important updates about IMAPAC and its partners to keep you in the loop.


    By checking the box above, you acknowledge and agree to IMAPAC’s Terms of Service and to use your contact information provided to communicate with you about offerings by IMAPAC, its brands, affiliates and/or third-party partners consistent with IMAPAC’s Privacy Policy.

    Events

    Thought leadership, industry knowledge-sharing and quality networking are at the core of IMAPAC's B2B events.

    Intelligence

    In-depth biopharmaceutical industry intelligence brought to you by our team of analysts.

    LeadGen 360

    Expand your influence, be it through branding & display ads, content creation or thought leadership.

    Community

    Linking professionals and fostering conversations among the biopharmaceutical industry professionals.
    bag